Clonazepam Tablet Shortage
Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.
| Company | Brand name | Status | Last updated |
|---|---|---|---|
| Accord Healthcare Inc. | CLONAZEPAM | Current | 07/17/2026 |
| Accord Healthcare Inc. | CLONAZEPAM | Current | 07/17/2026 |
| Accord Healthcare Inc. | CLONAZEPAM | Current | 07/17/2026 |
| Accord Healthcare Inc. | CLONAZEPAM | Current | 07/17/2026 |
| Accord Healthcare Inc. | CLONAZEPAM | Current | 07/17/2026 |
| Accord Healthcare Inc. | CLONAZEPAM | Current | 07/17/2026 |
| Teva Pharmaceuticals USA, Inc. | CLONAZEPAM | Current | 07/15/2026 |
| Teva Pharmaceuticals USA, Inc. | CLONAZEPAM | Current | 07/15/2026 |
| Cheplapharm Arzneimittel GmbH | KLONOPIN | Current | 07/15/2026 |
| Cheplapharm Arzneimittel GmbH | KLONOPIN | Current | 07/15/2026 |
| Teva Pharmaceuticals USA, Inc. | CLONAZEPAM | Current | 07/15/2026 |
| Teva Pharmaceuticals USA, Inc. | CLONAZEPAM | Current | 07/15/2026 |
| Cheplapharm Arzneimittel GmbH | KLONOPIN | Current | 07/15/2026 |
| Teva Pharmaceuticals USA, Inc. | CLONAZEPAM | Current | 07/15/2026 |
| Teva Pharmaceuticals USA, Inc. | CLONAZEPAM | Current | 07/15/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Prinston Pharmaceutical, Inc. | CLONAZEPAM | Current | 07/01/2026 |
| Aurobindo Pharma USA | CLONAZEPAM | Current | 06/02/2026 |
| Aurobindo Pharma USA | CLONAZEPAM | Current | 06/02/2026 |
| Aurobindo Pharma USA | CLONAZEPAM | Current | 06/02/2026 |
| Aurobindo Pharma USA | CLONAZEPAM | Current | 06/02/2026 |
| Aurobindo Pharma USA | CLONAZEPAM | Current | 06/02/2026 |
| Aurobindo Pharma USA | CLONAZEPAM | Current | 06/02/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |
| Rubicon Research Private Limited | CLONAZEPAM | Current | 06/01/2026 |